Bill Commons

MI SB 94

in committee

Health: pharmaceuticals; drug manufacturers from engaging in certain conduct with pharmacies participating with a 340B program; prohibit. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 17757c. TIE BAR WITH: SB 0095'25

Michigan · 2025-2026 Regular Session (103rd Legislature) · upper

Follow this bill’s action updates (Atom)

Subscribe in a feed reader. The feed covers recorded actions from the last 30 days; Bill Commons may record an action after it happened at the legislature.

Quick answers

Did MI SB 94 pass?

Not yet. MI SB 94 is in committee and has not come to a final vote. Latest recorded action (2025-03-06): referred to Committee on Health Policy

What is MI SB 94 about?

MI SB 94 is a bill in the 2025-2026 Regular Session (103rd Legislature) titled “Health: pharmaceuticals; drug manufacturers from engaging in certain conduct with pharmacies participating with a 340B program; prohibit. Amends 1978 PA 368 (MCL 333.1101 - 333.25211) by adding sec. 17757c. TIE BAR WITH: SB 0095'25”.

Who sponsors MI SB 94?

Sam Singh is the primary sponsor of MI SB 94, joined by 9 cosponsors.

Introduced
2025-02-20
Latest action
2025-03-06 — referred to Committee on Health Policy
Bill type
bill
Last updated
—

Subjects

Sponsors

  • Sam Singhprimary
  • Kevin Hertelcosponsor
  • Mallory McMorrowcosponsor
  • Stephanie Changcosponsor
  • Sue Shinkcosponsor
  • Rosemary Bayercosponsor
  • John Damoosecosponsor
  • Jonathan Lindseycosponsor
  • Joseph N. Bellino Jr.cosponsor
  • Rick Outmancosponsor

Committees

Not provided by source.

Action timeline

Newest first

  1. 2025-03-06

    referred to Committee on Health Policy

    referral-committee

  2. 2025-03-06

    read a first time

    reading-1

  3. 2025-03-06

    received on 03/06/2025

    introduction

  4. 2025-03-06

    PASSED ROLL CALL # 15 YEAS 33 NAYS 3 EXCUSED 1 NOT VOTING 0

    passage

  5. 2025-03-05

    PLACED ON ORDER OF THIRD READING

  6. 2025-03-05

    REPORTED BY COMMITTEE OF THE WHOLE FAVORABLY WITHOUT AMENDMENT(S)

    committee-passage

  7. 2025-03-05

    RULES SUSPENDED FOR IMMEDIATE CONSIDERATION

  8. 2025-02-26

    REFERRED TO COMMITTEE OF THE WHOLE

    referral-committee

  9. 2025-02-26

    REPORTED FAVORABLY WITHOUT AMENDMENT 2/27/2025

    committee-passage

  10. 2025-02-26

    SENATE CO-SPONSOR(S) NAMED: ROSEMARY BAYER

  11. 2025-02-20

    REFERRED TO COMMITTEE ON OVERSIGHT

    referral-committee

  12. 2025-02-20

    INTRODUCED BY SENATOR SAM SINGH

    introduction

Versions

Documents

Votes

  • PASSED ROLL CALL # 15 YEAS 33 NAYS 3 EXCUSED 1 NOT VOTING 0

    2025-03-06 · pass · 33-3

    Member-level votes (37)
    • Albert: yes
    • Daley: yes
    • Klinefelt: yes
    • Polehanki: yes
    • Anthony: yes
    • Damoose: yes
    • Lauwers: yes
    • Runestad: yes
    • Bayer: yes
    • Geiss: yes
    • Lindsey: yes
    • Shink: yes
    • Bellino: yes
    • Hauck: yes
    • McBroom: yes
    • Singh: yes
    • Brinks: yes
    • Hertel: yes
    • McCann: yes
    • Theis: yes
    • Bumstead: yes
    • Hoitenga: yes
    • McMorrow: yes
    • Victory: yes
    • Cavanagh: yes
    • Irwin: yes
    • Moss: yes
    • Webber: yes
    • Chang: yes
    • Johnson: yes
    • Outman: yes
    • Wojno: yes
    • Cherry: yes
    • Huizenga: no
    • Nesbitt: no
    • Santana: no
    • Camilleri: other

Related bills

No related bills recorded for this bill.

Official source

Attribution

Data from openstates_bulk_csv, retrieved 2026-07-24T05:24:27.556085Z

Inspect retained evidence for changes recorded after evidence tracking began:

Session-wide evidence can include changes to other bills:

Use this data

Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=MI&identifier=SB 94. See the API docs or the MCP server for AI assistants.

Known limitations

  • Sponsor party and chamber affiliation are not yet captured by this API.
  • Committee referrals are not yet captured.

See the methodology page for data sources and limitations.